Qingyu Luo
-
- Cancer, Hypoxia, and Metabolism 2
-
- Ubiquitin and proteasome pathways 7
- Chromatin Remodeling and Cancer 4
- RNA modifications and cancer 4
- Protein Degradation and Inhibitors 3
-
- Cancer-related Molecular Pathways 4
-
- Cancer Mechanisms and Therapy 4
-
- Chronic Lymphocytic Leukemia Research 2
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Qingyu Luo
19 papers receiving 535 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 128
- Molecular Biology 425
- Oncology 162
- Pathology and Forensic Medicine 64
- Cell Biology 39
Countries citing papers authored by Qingyu Luo
This map shows the geographic impact of Qingyu Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyu Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyu Luo more than expected).
Fields of papers citing papers by Qingyu Luo
This network shows the impact of papers produced by Qingyu Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyu Luo. The network helps show where Qingyu Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qingyu Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 12 | |
| 4 | 2024 | 17 | |
| 5 | 2023 | 15 | |
| 6 | 2023 | 9 | |
| 7 | 2022 | 23 | |
| 8 | 2022 | 19 | |
| 9 | 2022 | 28 | |
| 10 | 2022 | 19 | |
| 11 | 2022 | 11 | |
| 12 | 2021 | 55 | |
| 13 | 2020 | 9 | |
| 14 | 2020 | 59 | |
| 15 | 2020 | 40 | |
| 16 | 2020 | 19 | |
| 17 | 2019 | 35 | |
| 18 | 2019 | 54 | |
| 19 | 2018 | 17 | |
| 20 | 2018 | 34 |
About Qingyu Luo
Qingyu Luo is a scholar working on Pathology and Forensic Medicine, Cancer Research and Oncology, having authored 21 papers that have together received 540 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (7 papers), Cancer Mechanisms and Therapy (4 papers), Chromatin Remodeling and Cancer (4 papers), RNA modifications and cancer (4 papers), Cancer-related Molecular Pathways (4 papers), Protein Degradation and Inhibitors (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (128 citations), Molecular Biology (425 citations) and Oncology (162 citations). Qingyu Luo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiaowei Wu, Zhihua Liu, Pengfei Zhao, Wan Chang, Yabing Nan, Tong Shu, Fang Ding, Dan Su, Yating Wang and Xiaolin Zhu. Their work appears in journals such as Cell Reports, Cell Death and Differentiation, Cancer Letters, Proceedings of the National Academy of Sciences and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.